Past events

3.30–4.30pm 12 August 2016
Di Hu, The Potas Group, Eccles Institute of Neuroscience, JCSMR, ANU       
3.30–4.30pm 12 August 2016
Timothy McInerney, The John Curtin School of Medical Research, The Australian National University Character Compatibility Analysis Part II Investigating the causes of phylogenetic collapse in human mitochondria In the...
12–1pm 12 August 2016
Professor Susan Clark, Division of Genomics and Epigenetics, Garvan Institute of Medical Research, Sydney, NSW A three-dimensional chromatin state underpins the structural and functional basis of the genome by bringing...
5.15–6pm 10 August 2016
Professor Frank Bowden, Infectious Diseases Expert, ANU Medical School, The Australian National University, Canberra, ACT Frank is an infectious diseases physician at Canberra Hospital, and author of the newly released book:...
3.30–4.30pm 5 August 2016
Mr John Pearce, The Maddess Group, Eccles Institute of Neuroscience, JCSMR, ANU      
3.30–4.30pm 5 August 2016
Shaun Lehmann, The John Curtin School of Medical Research, ANU Phylogenetic studies of mitochondrial genomes have played an important role in exploring human evolution, migration patterns, and the relationships between...
12–1pm 5 August 2016
Dr Sarah-Jane Dawson, Molecular Biomarkers and Translational Genomics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC Cell-free circulating DNA containing tumor-specific sequences can be identified in the plasma of...
12–1pm 3 August 2016
Kathryn McKeon, The Vinuesa Group Investigating how genetic variants in BANK1 and BLK lead to a loss of B cell tolerance Anselm Enders, The Enders Group BCR signalling in SPP2A deficiency
12–1pm 29 July 2016
Professor John Rasko AO, Sydney Medical School, University of Sydney, Head, Gene and Stem Cell Therapy Program, Centenary Institute, Head of Department, Cell & Molecular Therapies, Royal Prince Alfred Hospital...
3.30–4.30pm 28 July 2016
Deriving murine transformed hepatocytes in primary culture: novel technique and potential utility. Dr Sharon Pok, ANUMS   This seminar will be followed by drinks in the Tea Room
12–1pm 27 July 2016
Katharine Bassett, The Vinuesa Group, JCSMR: Exploring the role of a novel gene variant in Lupus Pathogenesis Brigette Boast,The Enders Group, JCSMR: PAX5 in B cell and tumor development
12–1pm 22 July 2016
Dr Kelli McDonald, Antigen Presentation Laboratory and Immunoregulation, QIMR Berghofer Medical Research Institute, Qld.  Chronic graft-versus-host disease (cGVHD) is currently the major cause of non-relapse mortality...
12–1pm 21 July 2016
Dr Partha Pratim Das, Department of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA The roles of histone demethylases (HDMs) in ESCs identity are incompletely defined. In this study, we showed that...
3.30–4.30pm 15 July 2016
Reed A. Cartwright, Arizona State University, USA Studying the process of de novo mutation from deep-sequencing of related samples is a difficult task. Because de novos are rare, artifacts generated by experimental and...
10.30–11.30am 12 July 2016
Professor John Barbur, Applied Vision Research Centre, The Henry Wellcome Laboratories for Vision Sciences, City University London, UK Significant advances in our understanding of the genetics of colour vision make it possible...
9am–4.30pm 5 July 2016
Hear how European Molecular Biology Laboratory (EMBL) Australia researchers are contributing to Australia’s research output. This is a great opportunity for early career researchers to come and hear internationally...
5.30–6.15pm 4 July 2016
Professor Matthias Hentze, Director, EMBL, Heidelberg and Co-Director, University of Heidelberg Molecular Medicine Partnership Unit, Heidelberg, Germany The molecular life sciences and biomedical research can help address key...
3.30–4.30pm 1 July 2016
SMBE Practice Presentations:15 minutes presentations in random order: Maja Adamska: Transcriptional activation of Wnt and TGF-beta signaling pathways in regeneration of sponges Yicheng Zhu: Diagnostic sequence motifs...
12–1pm 1 July 2016
Dr Clare Smith, University of Massachusetts Medical School, Worcester, MA, USA Genetic variations in both host and pathogen underlie outcome to infection. Dr Clare Smith has developed a “dual-genome” system to...

Pages

Updated:  21 September 2017/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager